These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21566237)

  • 1. Outcomes of intravenous thrombolysis after dissemination of the stroke code and designation of new referral hospitals in Catalonia: the Catalan Stroke Code and Thrombolysis (Cat-SCT) Monitored Study.
    Abilleira S; Dávalos A; Chamorro A; Alvarez-Sabín J; Ribera A; Gallofré M;
    Stroke; 2011 Jul; 42(7):2001-6. PubMed ID: 21566237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Hospital Type on Outcomes of Individuals Aged 80 and Older with Stroke Treated Using Intravenous Thrombolysis.
    Purroy F; Vena A; Cánovas D; Cardona P; Cocho D; Cuadrado-Godia E; Chamorro A; Dávalos A; Garcés M; Gomis M; Krupinski J; Palomeras E; Ribó M; Roquer J; Rubiera M; Sanahuja J; Saura J; Serena J; Ustrell X; Vargas M; Benabdelhak I; Abilleira S; Gallofré M;
    J Am Geriatr Soc; 2017 Sep; 65(9):E117-E122. PubMed ID: 28574595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series.
    Tsivgoulis G; Alexandrov AV; Chang J; Sharma VK; Hoover SL; Lao AY; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Frey JL
    Stroke; 2011 Jun; 42(6):1771-4. PubMed ID: 21493900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?
    Fuentes B; Masjuan J; Alonso de Leciñana M; Simal P; Egido J; Díaz-Otero F; Gil-Nuñez A; Martínez-Sánchez P; Díez-Tejedor E;
    Int J Stroke; 2012 Jan; 7(1):7-13. PubMed ID: 22017881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.
    Tsivgoulis G; Sharma VK; Mikulik R; Krogias C; Haršány M; Bavarsad Shahripour R; Athanasiadis D; Teoh HL; Piperidou C; Alexandrov AV
    Int J Stroke; 2014 Jun; 9(4):413-8. PubMed ID: 23981541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S; Dharmasaroja P; Kummark U
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of long-term outcome after intravenous or intra-arterial recombinant tissue plasminogen activator treatment in the eastern Hungarian thrombolysis database.
    Fekete K; Márton S; Tóth J; Csiba L; Fekete I; Bereczki D
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):117-24. PubMed ID: 25440339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.
    Arnold M; Mattle S; Galimanis A; Kappeler L; Fischer U; Jung S; De Marchis GM; Gralla J; Mono ML; Brekenfeld C; Meier N; Nedeltchev K; Schroth G; Mattle HP
    Int J Stroke; 2014 Dec; 9(8):985-91. PubMed ID: 22973986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.
    Gerischer LM; Fiebach JB; Scheitz JF; Audebert HJ; Endres M; Nolte CH
    Cerebrovasc Dis; 2013; 35(3):250-6. PubMed ID: 23548768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke.
    Sarikaya H; Arnold M; Engelter ST; Lyrer PA; Mattle HP; Georgiadis D; Bonati LH; Fluri F; Fischer U; Findling O; Ballinari P; Baumgartner RW
    Stroke; 2011 Sep; 42(9):2498-502. PubMed ID: 21778443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Sung SF; Chen SC; Lin HJ; Chen YW; Tseng MC; Chen CH
    Stroke; 2013 Jun; 44(6):1561-6. PubMed ID: 23632979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis.
    Seet RC; Zhang Y; Wijdicks EF; Rabinstein AA
    Arch Neurol; 2011 Nov; 68(11):1454-8. PubMed ID: 22084129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G
    Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis in ischemic stroke without arterial occlusion at presentation.
    Lahoti S; Gokhale S; Caplan L; Michel P; Samson Y; Rosso C; Limaye K; Hinduja A; Singhal A; Ali S; Pettigrew LC; Kryscio R; Dedhia N; Hastak S; Liebeskind DS
    Stroke; 2014 Sep; 45(9):2722-7. PubMed ID: 25074517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.